Total Products under this Category: 206
Last updated: November 13, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.
Highlighted products: ULTRUS® ComplianceWire, SciLeads, Verifarma T&T, BioRender, Microsoft Genomics, Advarra eReg, StudyTeam, and AmpleLogic Annual Product Quality Review (APQR).
Underlying data: [Grid® JSON](https://www.g2.com/categories/other-life-sciences/grids.json?focus%5B%5D=ul-solutions-ultrus-compliancewire&focus%5B%5D=scileads&focus%5B%5D=verifarma-t-t&focus%5B%5D=biorender&focus%5B%5D=microsoft-genomics&focus%5B%5D=advarra-ereg&focus%5B%5D=studyteam&focus%5B%5D=amplelogic-annual-product-quality-review-apqr)
DF mSafety AI is a cloud-based safety platform that uses the power of AI/ML and automation to deliver efficiencies and a great user experience in Safety Case Management and Signal Detection for Drugs, Cosmetics, Vaccines, Neutraceutical and Medical Devices.
DF mSignal AI is a powerful signal management system for drug, cosmetics, vaccines, nutraceuticals,food supplement and medical devices, that offers advanced, accurate and comprehensive coverage of signal detection and risk management. Based on product-event combinations, DF mSignal AI provides a powerful set of analytics and insights that enable active and passive surveillance of signals. Statistical scores are automatically generated from safety data ingested from multiple regulatory agency portals and company safety database/s. Multi-format data representations enable users to monitor potential risks and generate signal reports collaboratively.
Direct-to-Digital Staining is PathScience’s approach to creating stain-like pathology images digitally from unstained tissue scans. In a traditional digital pathology workflow, tissue is usually chemically stained before it is scanned, viewed, managed, or analyzed. Direct-to-Digital Staining moves part of that process upstream by using imaging and machine learning techniques to generate H&E-style virtual stain images from unstained tissue. The approach is intended to support pathologist-centered review and pathology workflows, especially in areas such as dermatopathology and Mohs surgery where tissue visualization, turnaround time, and tissue preservation are important. Direct-to-Digital Staining is not autonomous diagnostic AI and is not intended to replace pathologists. It is an image-generation and workflow-support technology designed to create familiar, interpretable pathology images while reducing reliance on traditional chemical staining steps.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
DrugDev’s Solution integrates all of your investigator and site information to deliver a single, unified source that can be leveraged in master data management as well as in support of study planning, site identification, and site qualification.
eAdjudication ® supports Endpoint Adjudication with a user-friendly Cloud Software exclusively designed to support Study Leaders, Committee Members and the Q.A. Staff across the central review & assessment of subjective or image based endpoints. eAdjudication software is provided as an all-inclusive Cloud Service package bundled together with hosting, technical management, validation, training & support: > unlimited users Licenses of the software; > configuration to map the Adjudication Charter and Workflows; > ISO 27001 cloud hosting for system and database; > server, database and study data complete technical management; > standard users support / integrated online Helpdesk; > standard users training / testing in a Clone "Stage" environment; > GxP validation package documentation & support.
DSG Designer lets the user be the creator with complete control of workflow to help streamline trial execution. DSG Designer offers the design flexibility to mix and match your eCRFs in both a Table Layout and Free Form Layout together within the same study. DSG’s unparalleled support services and hands-on training ensure that you build studies end-to-end. We help you create reusable templates and eCRFs that can lower your cost to deliver a completed study for regulatory approval. Accelerate the design process with our complete and exhaustive library of pre-defined edits based on years of full service edc experience.
eCaseLink.Me provides a flexible approach to patient-reported data capture. eCaseLink.Me can be used alone or in combination with eCaseLink EDC software for reporting and data analysis. Designed with the patient in mind, eCaseLink.Me allows patients to personalize and change the appearance of the application to better suit preferences. It works on any browser or web-enabled device, so that patients may enter data conveniently from any wifi-enabled location – no need for unfamiliar devices.
eDeviation supports all the operations for Protocol Deviation assessment and management. From software design and validation to collecting supporting documents and exporting data for the TMF, eDeviation® relieves your clinical team from the risks associated with missing or wrongly assessing one-time or recurring protocol deviations.
Ennov Event is a comprehensive pharmaceutical event management software, and provides: Event management: Complete management of professional events for pharmaceutical companies, with a modern web interface, delegation to your service provider agencies, global and centralized management of your expenses, automatically generated websites for event participants, integrated stand management and a responsive sales force interface Regulatory Compliance: comply with DMOS, Bertrand law, EFPIA declaration code, Transparency and reporting of "sunshine act" links of interest. Contract Management: Manage your contracts more efficiently and rigorously through automated contract generation, legal validation and traceability, electronic signature of contracts.
eWizard is a content experience platform designed specifically for the pharmaceutical and life sciences industries, enabling marketing teams to create, manage, and distribute high-quality, interactive digital content across multiple channels — without requiring coding expertise. From eDetailers, marketing emails, and landing pages to videos, banners, and messenger ads, eWizard simplifies content creation and streamlines omnichannel content operations, ensuring consistency, compliance, and efficiency. 1. No-code content creation & modular approach eWizard’s intuitive drag-and-drop editor allows marketing professionals to build and edit digital assets effortlessly. The platform’s modular content capabilities let teams reuse, repurpose, and adapt content efficiently, saving time while maintaining brand consistency. 2. Create Once – Publish Everywhere (COPE) strategy With eWizard’s COPE approach, content is created once and seamlessly adapted for multiple formats and channels. This strategy eliminates duplication, speeds up localization, and ensures consistent messaging across HCP portals, email campaigns, websites, and social platforms. 3. Omnichannel publishing & seamless integrations eWizard integrates with industry-leading platforms like Veeva Vault, Salesforce Marketing Cloud, and Adobe Experience Manager, enabling direct content distribution. 4. Advanced content localization & compliance Pharma marketers must navigate complex regulatory environments and global market demands. eWizard simplifies content localization and compliance approvals, making it easier to adapt assets for different languages, regulatory requirements, and audience preferences. - Built-in compliance workflows to meet industry standards - AI-powered automation for faster approvals and version control - Localization tools to accelerate content adaptation across global markets 5. Smarter content operations & workflow automation eWizard enhances content operations by streamlining review, approval, and distribution processes. Built-in collaboration tools allow cross-functional teams to manage projects efficiently, ensuring content is always up-to-date, compliant, and optimized for engagement. Why choose eWizard? ✔ Faster time-to-market – Reduce content creation time with a no-code, modular system ✔ Seamless omnichannel engagement – Publish across web, CRM, email, and social with one click ✔ Regulatory compliance & governance – Keep content audit-ready with integrated approval workflows ✔ Optimized content performance – Ensure engaging, personalized digital experiences across all touchpoints Who is eWizard perfect for? eWizard is built for pharmaceutical companies, biotech firms, and healthcare marketers looking to enhance digital engagement, optimize workflows, and ensure compliance in their marketing strategies. Whether you’re managing HCP communications, patient engagement, or omnichannel pharma marketing campaigns, eWizard provides a scalable, efficient, and compliance-friendly solution that transforms the way life sciences companies create and manage content.
Activate remote site start-up, monitoring, and source data review/verification on SiteLink™. Connect and deploy Florence eBinders™, the industry-standard electronic Investigator Site File and Electronic Participant Binder, on a global scale to every site in your study.
FormularyDecisions is a digital platform that supports the exchange of information between healthcare decision makers (HCDMs) and biopharma companies, with the goal of accelerating formulary placement decisions. Registered HCDMs on the platform represent over 288 million pharmacy benefit manager covered lives and more than 1,200 private and public payer organizations across the US. With FormularyDecisions, HCDMs can access evidence for thousands of products—all from one platform. This includes information on over 3,700 FDA-approved and pipeline products, plus a centralized repository of more than 1 million evidence links to leading scientific resources. The platform enables biopharma companies to share information on their products throughout the product lifecycle and HCDMs to request clinical and economic information from biopharma companies as well as to share their HCDM expertise and insights.
Accelerate Real World Evidence Generation from months to minutes for internal hypothesis testing from your own data
